ARYA Sciences Acquisition Corp IV
Unit Split
Follow
Detailed Information
Information on this SPAC.
- IPO Size
- $130M
- Underwriters
- Focus
- Healthcare, Life Sciences, Technology
- SEC Filings
- 1838821
- Public Embarc Page
- https://embarc.com/capital/spac/1838821/ARYD/arya-sciences-acquisition
- IPO Ticker
- ARYD
SPAC Leadership
Information on the SPAC leadership.
- ChairmanJoseph Edelman(Founder/CEO, Perceptive Advisors)
- Chief Executive Officer and DirectorAdam Stone
- Chief Financial Officer and DirectorMichael Altman, CFA
- Chief Business OfficerKonstantin Poukalov
- DirectorTodd Wider, M.D.
- DirectorLeslie Trigg
- DirectorMichael Henderson, M.D.